Models of cervical screening in the era of human papillomavirus vaccination
- 1 January 2010
- journal article
- review article
- Published by CSIRO Publishing in Sexual Health
- Vol. 7 (3) , 359-367
- https://doi.org/10.1071/sh10016
Abstract
Epidemiologic and economic evaluation using simulation modelling can support complex policy decisions, and is an important tool in predicting the future interaction between human papillomavirus vaccination and cervical screening. Several categories of screening program evaluation are of interest, including: (1) changes to screening considered over the short term, over which the effects of vaccination should be confined to the youngest age groups (<30 years old); (2) the medium and long-term effect of vaccination on the screening program; and (3) changes to screening in context of vaccination. This review considers some of the policy questions in each category and discusses the modelling implications, with particular focus on the Australian context.Keywords
This publication has 40 references indexed in Scilit:
- Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort studyPublished by Elsevier ,2008
- The cost‐effectiveness of cervical screening in Australia: what is the impact of screening at different intervals or over a different age range?Australian and New Zealand Journal of Public Health, 2008
- Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccinationPopulation Health Metrics, 2007
- HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility?Health Economics, 2007
- Multiparameter Calibration of a Natural History Model of Cervical CancerAmerican Journal of Epidemiology, 2007
- Modeling Human Papillomavirus Vaccine Effectiveness: Quantifying the Impact of Parameter UncertaintyAmerican Journal of Epidemiology, 2007
- A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening ProgramSexual Health, 2007
- Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortalityThe Medical Journal of Australia, 2006
- An alternative cost effectiveness analysis of ThinPrep in the Australian settingAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2005
- Cervical screening: time to change the policyThe Medical Journal of Australia, 2002